Reirradiation Registry Study
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Lung Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | June 2012 |
Registry Study of Thoracic Reirradiation for Non-Small Cell Lung Cancer (NSCLC) Utilizing Proton Beam Therapy or Intensity Modulated Radiation Therapy
The goal of this research study is to learn more about the safety of treating NSCLC with
reirradiation using standard methods and to look for ways to lessen side effects and improve
therapy. Reirradiation is when radiation is given to an area of the body that has previously
received a full dose of radiation.
reirradiation using standard methods and to look for ways to lessen side effects and improve
therapy. Reirradiation is when radiation is given to an area of the body that has previously
received a full dose of radiation.
If you agree to take part in this study, data will be recorded during your therapy. The data
to be recorded will include your medical history, the disease, treatments you have received
and how you have responded to any treatments, as well as any side effects you may have had.
The data will be stored on a password-protected computer at MD Anderson for use in future
research related to cancer.
Your data will be given a code number. No identifying information will be directly linked to
your data. Only the researcher in charge of this study will have access to the code numbers
and be able to link the data to you. This is to allow medical information related to your
data to be updated as needed. Other researchers using your data will not be able to link
this data to you.
Length of Study:
After you sign this consent form, your active participation on this study will be over.
This is an investigational study.
Up to 120 patients will take part in this study. All will be enrolled at MD Anderson.
to be recorded will include your medical history, the disease, treatments you have received
and how you have responded to any treatments, as well as any side effects you may have had.
The data will be stored on a password-protected computer at MD Anderson for use in future
research related to cancer.
Your data will be given a code number. No identifying information will be directly linked to
your data. Only the researcher in charge of this study will have access to the code numbers
and be able to link the data to you. This is to allow medical information related to your
data to be updated as needed. Other researchers using your data will not be able to link
this data to you.
Length of Study:
After you sign this consent form, your active participation on this study will be over.
This is an investigational study.
Up to 120 patients will take part in this study. All will be enrolled at MD Anderson.
Inclusion Criteria:
1. History of previous histologically or cytologically documented NSCLC, stage I-IV.
2. Prior course of radiation therapy or concurrent chemoradiation at least 1 month prior
to the current course of radiation therapy.
3. Patients eligible to receive a second course of radiation therapy to the thorax, at
the discretion of the treating physician.
4. Patients receiving concurrent chemotherapy or targeted agents will be eligible for
this protocol.
3.2 Exclusion Criteria:
1. Life expectancy<3 months
2. Pregnancy.
We found this trial at
1
site
1515 Holcombe Blvd
Houston, Texas 77030
Houston, Texas 77030
713-792-2121
University of Texas M.D. Anderson Cancer Center The mission of The University of Texas MD...
Click here to add this to my saved trials
